{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T03:06:40Z","timestamp":1785467200791,"version":"3.56.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T00:00:00Z","timestamp":1653782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejpb.2022.05.016","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T09:29:50Z","timestamp":1653816590000},"page":"199-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Single versus double occupancy solid lipid nanoparticles for delivery of the dual-acting bacteriocin, lacticin 3147"],"prefix":"10.1016","volume":"176","author":[{"given":"Aoibh\u00edn","family":"Ryan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratikkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7054-7322","authenticated-orcid":false,"given":"Jennifer","family":"Cookman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Paul","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6718-2190","authenticated-orcid":false,"given":"Sarah P.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0005","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro2937","article-title":"Bacteriocins\u2014a viable alternative to antibiotics?","volume":"11","author":"Cotter","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0010","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1128\/aem.62.2.612-619.1996","article-title":"An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147","volume":"62","author":"Ryan","year":"1996","journal-title":"Appl. Environ. Microbiol."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1365-2958.2006.05223.x","article-title":"The mode of action of the lantibiotic lacticin 3147\u2013a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II","volume":"61","author":"Wiedemann","year":"2006","journal-title":"Mol. Microbiol."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1472-765x.2001.00864.x","article-title":"Heterologous expression of lacticin 3147 in Enterococcus faecalis: comparison of biological activity with cytolysin","volume":"32","author":"Ryan","year":"2001","journal-title":"Lett. Appl. Microbiol."},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.016_b0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/jac\/dkp221","article-title":"A comparison of the activities of lacticin 3147 and nisin against drug-resistant staphylococcus aureus and enterococcus species","volume":"64","author":"Piper","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"issue":"7","key":"10.1016\/j.ejpb.2022.05.016_b0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1099\/jmm.0.47085-0","article-title":"Antimicrobial activity of lacticin 3147 against clinical Clostridium difficile strains","volume":"56","author":"Rea","year":"2007","journal-title":"J. Med. Microbiol."},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.016_b0035","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1574-6941.2011.01069.x","article-title":"Fate and efficacy of lacticin 3147-producing lactococcus lactis in the mammalian gastrointestinal tract","volume":"76","author":"Dobson","year":"2011","journal-title":"FEMS Microbiol. Ecol."},{"key":"10.1016\/j.ejpb.2022.05.016_b0040","unstructured":"O'Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations amr-review.org2016 [Available from: https:\/\/amr-review.org\/sites\/default\/files\/160525_Final%20paper_with%20cover.pdf."},{"key":"10.1016\/j.ejpb.2022.05.016_b0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejpb.2021.05.015","article-title":"Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics","volume":"165","author":"Flynn","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"49","key":"10.1016\/j.ejpb.2022.05.016_b0050","doi-asserted-by":"crossref","first-page":"17803","DOI":"10.1021\/jacs.7b04728","article-title":"Insights into the mechanism of action of the two-peptide lantibiotic lacticin 3147","volume":"139","author":"Bakhtiary","year":"2017","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0055","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/AEM.64.2.439-445.1998","article-title":"Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential","volume":"64","author":"McAuliffe","year":"1998","journal-title":"Appl. Environ. Microbiol."},{"issue":"7","key":"10.1016\/j.ejpb.2022.05.016_b0060","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/AAC.49.7.2606-2611.2005","article-title":"Sequential actions of the two component peptides of the lantibiotic lacticin 3147 explain its antimicrobial activity at nanomolar concentrations","volume":"49","author":"Morgan","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"issue":"45","key":"10.1016\/j.ejpb.2022.05.016_b0065","doi-asserted-by":"crossref","first-page":"26777","DOI":"10.1039\/D0RA03491F","article-title":"A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems","volume":"10","author":"Duan","year":"2020","journal-title":"RSC Adv."},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.016_b0070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157016311796799062","article-title":"20 years of lipid nanoparticles (SLN & NLC): present state of development & industrial applications","volume":"8","author":"Muller","year":"2011","journal-title":"Curr. Drug Discov. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.05.016_b0075","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery\u2013a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2012.09.021","article-title":"Solid lipid nanoparticles: production, characterization and applications","volume":"64","author":"Mehnert","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2022.05.016_b0085","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.msec.2016.05.119","article-title":"Solid lipid nanoparticles as attractive drug vehicles: Composition, properties and therapeutic strategies","volume":"68","author":"Geszke-Moritz","year":"2016","journal-title":"Mater. Sci. Eng., C"},{"key":"10.1016\/j.ejpb.2022.05.016_b0090","series-title":"Lipid nanoparticulate systems: Modern versatile drug carriers","first-page":"49","author":"Rawal","year":"2018"},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ejpb.2011.11.002","article-title":"Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA","volume":"80","author":"Yu","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0100","doi-asserted-by":"crossref","unstructured":"SS, Montoto G, Muraca ME, Ruiz Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Frontiers in Molecular Biosciences. 2020;7.","DOI":"10.3389\/fmolb.2020.587997"},{"issue":"9","key":"10.1016\/j.ejpb.2022.05.016_b0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3390\/ph13090255","article-title":"Eluxadoline loaded solid lipid nanoparticles for improved colon targeting in rat model of ulcerative Colitis","volume":"13","author":"Anwer","year":"2020","journal-title":"Pharmaceuticals."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1208\/s12249-016-0505-3","article-title":"Design and characterization of metformin-loaded solid lipid nanoparticles for colon cancer","volume":"18","author":"Ngwuluka","year":"2017","journal-title":"AAPS PharmSciTech."},{"issue":"6","key":"10.1016\/j.ejpb.2022.05.016_b0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7150\/ijms.7.398","article-title":"Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer","volume":"7","author":"Yassin","year":"2010","journal-title":"Int. j. med. Sci."},{"key":"10.1016\/j.ejpb.2022.05.016_b0120","doi-asserted-by":"crossref","first-page":"111305","DOI":"10.1016\/j.colsurfb.2020.111305","article-title":"Solid lipid nanoparticles for enhanced oral absorption: a review","volume":"196","author":"Salah","year":"2020","journal-title":"Colloids Surf., B"},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jfda.2017.02.001","article-title":"Recent advances in oral delivery of drugs and bioactive natural products using solid lipid nanoparticles as the carriers","volume":"25","author":"Lin","year":"2017","journal-title":"J. Food Drug Anal."},{"key":"10.1016\/j.ejpb.2022.05.016_b0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejpb.2017.04.013","article-title":"Surface modification of solid lipid nanoparticles for oral delivery of curcumin: Improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake","volume":"117","author":"Baek","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0135","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ejpb.2014.06.011","article-title":"Design and evaluation of solid lipid nanoparticles modified with peptide ligand for oral delivery of protein drugs","volume":"88","author":"Fan","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.05.016_b0140","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijpharm.2018.02.038","article-title":"Lipid-based nanosuspensions for oral delivery of peptides, a critical review","volume":"541","author":"Dumont","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/750891","article-title":"Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery","volume":"2012","author":"Severino","year":"2012","journal-title":"J. drug delivery."},{"key":"10.1016\/j.ejpb.2022.05.016_b0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.colsurfb.2015.03.049","article-title":"Sodium alginate-cross-linked polymyxin B sulphate-loaded solid lipid nanoparticles: antibiotic resistance tests and HaCat and NIH\/3T3 cell viability studies","volume":"129","author":"Severino","year":"2015","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2022.05.016_b0155","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejpb.2016.10.006","article-title":"Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: pharmacokinetic studies on rabbits","volume":"109","author":"Chetoni","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"4","key":"10.1016\/j.ejpb.2022.05.016_b0160","first-page":"1735","article-title":"Pharmaceutical design of a delivery system for the bacteriocin lacticin 3147. drug delivery and translational","volume":"11","author":"Ryan","year":"2021","journal-title":"Research."},{"issue":"5","key":"10.1016\/j.ejpb.2022.05.016_b0165","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1166\/jbn.2011.1332","article-title":"AmbiOnp: solid lipid nanoparticles of amphotericin B for oral administration","volume":"7","author":"Patel","year":"2011","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejpb.2022.05.016_b0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.colsurfb.2012.01.018","article-title":"Solid lipid nanoparticles: continuous and potential large-scale nanoprecipitation production in static mixers","volume":"94","author":"Dong","year":"2012","journal-title":"Colloids Surf., B"},{"key":"10.1016\/j.ejpb.2022.05.016_b0175","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ijpharm.2019.05.037","article-title":"In-vitro evaluation of solid lipid nanoparticles: ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract","volume":"565","author":"Dumont","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejpb.2018.09.019","article-title":"Delivery of a hydrophobic drug into the lower gastrointestinal system via an endogenous enzyme-mediated carrier mechanism: an in vitro study","volume":"133","author":"Bannigan","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0185","series-title":"Editors. validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests. veterinary research forumFaculty of veterinary medicine","author":"Naghili","year":"2013"},{"issue":"1\u20133","key":"10.1016\/j.ejpb.2022.05.016_b0190","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.colsurfa.2009.03.039","article-title":"Effect of nonionic and ionic surfactants on zeta potential and dispersion properties of carbon black powders","volume":"341","author":"Sis","year":"2009","journal-title":"Colloids Surf., A"},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.016_b0195","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/17425247.2020.1727883","article-title":"SLN and NLC for topical, dermal, and transdermal drug delivery","volume":"17","author":"Souto","year":"2020","journal-title":"Expert opinion on drug delivery."},{"key":"10.1016\/j.ejpb.2022.05.016_b0200","series-title":"Solid lipid nanoparticles","first-page":"221","author":"Jain","year":"2020"},{"key":"10.1016\/j.ejpb.2022.05.016_b0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.dib.2015.11.038","article-title":"Optimization of solid lipid nanoparticles prepared by a single emulsification-solvent evaporation method","volume":"6","author":"Pooja","year":"2016","journal-title":"Data in brief."},{"issue":"3","key":"10.1016\/j.ejpb.2022.05.016_b0210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ejps.2012.07.005","article-title":"Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer","volume":"47","author":"Ujhelyi","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2022.05.016_b0215","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2011.11.030","article-title":"Drug solubilization and in vitro toxicity evaluation of lipoamino acid surfactants","volume":"423","author":"M\u00e9nard","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2022.05.016_b0220","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1080\/17425247.2021.1982891","article-title":"Oral delivery of solid lipid nanoparticles: underlining the physicochemical characteristics and physiological condition affecting the lipolysis rate","volume":"18","author":"Mahmoudian","year":"2021","journal-title":"Expert Opinion on Drug Delivery."},{"issue":"6","key":"10.1016\/j.ejpb.2022.05.016_b0225","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1023\/A:1011032328064","article-title":"Size-dependent bioadhesion of micro-and nanoparticulate carriers to the inflamed colonic mucosa","volume":"18","author":"Lamprecht","year":"2001","journal-title":"Pharm. Res."},{"issue":"23","key":"10.1016\/j.ejpb.2022.05.016_b0230","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.3748\/wjg.v23.i23.4200","article-title":"Solid lipid nanoparticles delivering anti-inflammatory drugs to treat inflammatory bowel disease: effects in an in vivo model","volume":"23","author":"Dianzani","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ejpb.2022.05.016_b0235","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/03639045.2014.884127","article-title":"Curcumin nanoemulsion for transdermal application: formulation and evaluation","volume":"41","author":"Rachmawati","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2022.05.016_b0240","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/IJN.S100625","article-title":"Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity","volume":"11","author":"Aljaeid","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2022.05.016_b0245","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2009.09.008","article-title":"Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release","volume":"383","author":"Kim","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ejpb.2022.05.016_b0250","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/10837450.2018.1549075","article-title":"Optimization of nimesulide-loaded solid lipid nanoparticles (SLN) by factorial design, release profile and cytotoxicity in human Colon adenocarcinoma cell line","volume":"24","author":"Campos","year":"2019","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.05.016_b0255","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0168-3659(94)90047-7","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery. I. production, characterization and sterilization","volume":"30","author":"Schwarz","year":"1994","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122001126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:48:54Z","timestamp":1760546934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122001126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"alternative-id":["S0939641122001126"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.05.016","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single versus double occupancy solid lipid nanoparticles for delivery of the dual-acting bacteriocin, lacticin 3147","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}